======= KLF10 ======= == Gene Information == * **Official Symbol**: KLF10 * **Official Name**: Kruppel like factor 10 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7071|7071]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q13118|Q13118]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KLF10&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KLF10|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601878|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of a family of proteins that feature C2H2-type zinc finger domains. The encoded protein is a transcriptional repressor that acts as an effector of transforming growth factor beta signaling. Activity of this protein may inhibit the growth of cancers, particularly pancreatic cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]. * **UniProt Summary**: Transcriptional repressor which binds to the consensus sequence 5'-GGTGTG-3'. Plays a role in the regulation of the circadian clock; binds to the GC box sequence in the promoter of the core clock component ARTNL/BMAL1 and represses its transcriptional activity. Regulates the circadian expression of genes involved in lipogenesis, gluconeogenesis, and glycolysis in the liver. Represses the expression of PCK2, a rate-limiting step enzyme of gluconeogenesis (By similarity). May play a role in the cell cycle regulation. {ECO:0000250|UniProtKB:O89091, ECO:0000269|PubMed:8584037}. No Pfam Domain information is available for this gene. |core promoter sequence-specific DNA binding| |positive regulation of osteoclast differentiation| |bone mineralization| |positive regulation of myeloid leukocyte differentiation| |somatic stem cell population maintenance| |regulation of osteoclast differentiation| |positive regulation of myeloid cell differentiation| |biomineralization| |biomineral tissue development| |regulation of circadian rhythm| |regulation of myeloid leukocyte differentiation| |stem cell population maintenance| |maintenance of cell number| |circadian rhythm| |positive regulation of leukocyte differentiation| |cellular response to starvation| |positive regulation of hemopoiesis| |response to starvation| |regulation of myeloid cell differentiation| |cellular response to nutrient levels| |ossification| |cellular response to extracellular stimulus| |regulation of leukocyte differentiation| |rhythmic process| |cellular response to peptide| |cellular response to external stimulus| |DNA-binding transcription activator activity, RNA polymerase II-specific| |regulation of hemopoiesis| |response to peptide| |response to nutrient levels| |RNA polymerase II proximal promoter sequence-specific DNA binding| |response to extracellular stimulus| |cellular response to organonitrogen compound| |cellular response to nitrogen compound| |negative regulation of cell population proliferation| |DNA-binding transcription factor activity| |negative regulation of transcription by RNA polymerase II| |positive regulation of cell differentiation| |response to organonitrogen compound| |cellular response to oxygen-containing compound| |response to nitrogen compound| |cell-cell signaling| |positive regulation of immune system process| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of cell population proliferation| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of immune system process| |cellular response to stress| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|1.73| |[[:results:exp153|SGC2096 2.6μM R03 exp153]]|1.87| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16610 * **Expression level (log2 read counts)**: 2.93 {{:chemogenomics:nalm6 dist.png?nolink |}}